Automation in Biopharma and the Impact on Workflows

Automation in Biopharma
In this exclusive Drug Digest video interview, Meg Rivers and Feliza Mirasol, Pharmaceutical Technology editors, discuss the benefits of automating entire workflows in analytics versus automating only specific pieces of equipment or only certain processes with Nick Pattinson, head of product, Automata.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

See the Impossible: Navigating Pharma Procurement in a Complicated World

go.meetings-incentives

M&IW’s HMCC-certified buyers recently attended Pharma Forum and picked up the latest and greatest tips on sourcing healthcare meetings. In our next See the Impossible Webinar Series, learn how transparency, accountability and creative thinking can alleviate unnecessary back and forth and streamline the hotel procurement process.
Watch Now

Top 4 Quality Trends for 2019 Pharma Quality Outlook Survey

pharmtech

Economic performance could soon replace compliance as the leading quality goal for pharmaceutical companies. According to the 2019 Pharma Quality Outlook Survey, 66% of industry executives named compliance as a top goal, down 10% from last year. Meanwhile, more than one-third (39%) say that economic performance is now their top objective, a 4% increase.Join Sparta System's Steve McCarthy, VP of Digital Innovation, as he discusses key findings from this year's survey, which included responses from 161 professionals.
Watch Now

The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan

pharmaphorum

Brexit uncertainty isn’t going away any time soon – but it’s important to remember that the UK government has already set out two plans for the future shape of the country’s healthcare industry: the second Life Sciences Sector Deal and the long-term plan for the NHS. With these two plans in place there are plenty of opportunities for the industry and the government to work together to keep the UK at the top of the international life sciences sector – and perhaps reach even greater heights.
Watch Now

Tufts Research: Strategies from Data Management Leaders to Speed Clinical Trials

Honeycomb Worldwide Inc

Learn how top pharma and CROs plan to speed database build and data collection, as well as their top challenges and future priorities. Join this webinar to gain insights into Taking an agile approach to database buildReducing user acceptance testing (UAT) timelines with a risk-based approach. Driving innovation at your organization. This in-depth research from Tufts follows their industry-wide eClinical Landscape Study, examining the major cause of database build delays and their impact on trial cycle times.
Watch Now

Spotlight

resources